RIDEA joint-venture with Bickford acquires $135M for 17 assisted living, memory care communities

NewsGuard 100/100 Score

National Health Investors, Inc. (NYSE:NHI) announced today that its RIDEA joint-venture with Bickford Senior Living ("Bickford") has acquired 17 assisted living and memory care communities for a total purchase price of $135 million. NHI owns 85% of the joint-venture and Bickford owns 15%. The acquisition brings the total number of properties in the joint-venture to 30, of which 3 are under construction. Wells Fargo Securities, LLC served as financial advisor to NHI on this transaction.

“NHI has been the perfect partner for us since 2009”

The 17 assisted living and memory care communities are comprised of 14 communities purchased from a subsidiary of Care Investment Trust, Inc. (OTCQX:CVTR) for approximately $123 million, and 3 communities purchased from affiliates of Bickford for approximately $12 million.

Justin Hutchens, NHI's CEO and President stated, "This acquisition is evidence of the positive benefits of our joint-venture with Bickford which offers both organic and external growth potential. This relationship combines Bickford's twenty-plus years of experience in compassionately caring for seniors with the financial strength of NHI."

"NHI has been the perfect partner for us since 2009," said Bickford president Michael Eby. "Since we both share the same resident-focused philosophy, our growth plans are truly aligned. We are very excited about our future with Justin and his team as our partner."

Key Transaction Highlights

  • 17 facilities totaling 750 units with 90.6% average occupancy and an average age of 12 years
  • Locations: Illinois, Indiana, Iowa and Nebraska
  • 17 facilities have trailing twelve months net operating income of approximately $11.5 million after a 5% management fee to the operator and $500 per unit of capital expenditures
  • Acquisition financed by: (1) borrowings of approximately $56.2 million on NHI's revolving credit facility with interest rates of LIBOR plus 140bps; and (2) assumption of approximately $78.8 million of Fannie Mae secured debt maturing on July 1, 2015 (repayable without penalty December 31, 2014) with interest rates between 6.845% and 7.17%

Increase in 2013 Normalized FFO Guidance

The Company currently forecasts Normalized FFO for 2013 from $3.48 to $3.54 per diluted common share. The Company's guidance range for the full year 2013 for Normalized FFO per share, with underlying assumptions and timing of certain transactions, is set forth and reconciled below. The Company expects to report its results for the second quarter during the week of August 5, 2013.

The Company's guidance range reflects the existence of volatile economic conditions, but does not assume any material deterioration in tenant credit quality and/or performance of its portfolio. The guidance is based on a number of assumptions, many of which are outside the Company's control and all of which are subject to change. The low end of our guidance range assumes a baseline from the first quarter of 2013, the recently announced transactions, the timing for further terming out of debt on our revolving credit facility and assuming 3% growth from our Bickford joint venture. On the top end of that range, we are adding in assumptions for investment activity and a 6% growth from our Bickford joint venture. The Company expects to make new investments in health care real estate during the remainder of 2013 that meet its underwriting criteria and where the spreads over its cost of capital generate sufficient returns to its shareholders. These new investments are expected to be funded by the Company's liquid investments and by short-term and long-term debt financing. The Company's guidance may change if actual results vary from these assumptions.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.